207 related articles for article (PubMed ID: 30554541)
1. The journey for US psoriasis patients prescribed a topical: a retrospective database evaluation of patient progression to oral and/or biologic treatment.
Wu JJ; Lu M; Veverka KA; Smulders M; Papademetriou E; Yu J; Feldman SR
J Dermatolog Treat; 2019 Aug; 30(5):446-453. PubMed ID: 30554541
[No Abstract] [Full Text] [Related]
2. Real-world treatment patterns and healthcare costs among biologic-naive patients initiating apremilast or biologics for the treatment of psoriasis.
Wu JJ; Pelletier C; Ung B; Tian M
J Med Econ; 2019 Apr; 22(4):365-371. PubMed ID: 30652520
[TBL] [Abstract][Full Text] [Related]
3. The journey of adult psoriasis patients towards biologics: past and present - Results from the BioCAPTURE registry.
van den Reek JMPA; Seyger MMB; van Lümig PPM; Driessen RJB; Schalkwijk CJM; Berends MAM; van de Kerkhof PCM; de Jong EMGJ
J Eur Acad Dermatol Venereol; 2018 Apr; 32(4):615-623. PubMed ID: 29121430
[TBL] [Abstract][Full Text] [Related]
4. Persistence of treatment with biologics for patients with psoriasis: a real-world analysis of 16 545 biologic-naïve patients from the French National Health Insurance database (SNIIRAM).
Sbidian E; Mezzarobba M; Weill A; Coste J; Rudant J
Br J Dermatol; 2019 Jan; 180(1):86-93. PubMed ID: 29791721
[TBL] [Abstract][Full Text] [Related]
5. Biologic Therapy Utilization in Patients With Moderate to Severe Psoriasis and Psoriatic Arthritis: An Observational Summary of Biologic Therapy Use in a Clinical Setting.
Gulliver WP; Randell S; Gulliver S; Gregory V; Nagle S; Chambenoit O
J Cutan Med Surg; 2018; 22(6):567-576. PubMed ID: 29952225
[TBL] [Abstract][Full Text] [Related]
6. Reducing patient copayment levels for topical and systemic treatments in plaque psoriasis as a case for evidence-based, sustainable pharmaceutical policy change in Greece.
Souliotis K; Golna C; Kani C; Litsa P
J Med Econ; 2016 Nov; 19(11):1021-1026. PubMed ID: 27207488
[TBL] [Abstract][Full Text] [Related]
7. Treatment patterns, adherence, and persistence among psoriasis patients treated with biologics in a real-world setting, overall and by disease severity.
Murage MJ; Anderson A; Casso D; Oliveria SA; Ojeh CK; Muram TM; Merola JF; Zbrozek A; Araujo AB
J Dermatolog Treat; 2019 Mar; 30(2):141-149. PubMed ID: 29799292
[TBL] [Abstract][Full Text] [Related]
8. Prescribing Patterns Associated With Biologic Therapies for Psoriasis from a United States Medical Records Database.
Noe MH; Shin DB; Doshi JA; Margolis DJ; Gelfand JM
J Drugs Dermatol; 2019 Aug; 18(8):745-750. PubMed ID: 31424706
[TBL] [Abstract][Full Text] [Related]
9. A multinational, prospective, observational study to estimate complete skin clearance in patients with moderate-to-severe plaque PSOriasis treated with BIOlogics in a REAL world setting (PSO-BIO-REAL).
Seneschal J; Lacour JP; Bewley A; Faurby M; Paul C; Pellacani G; De Simone C; Horne L; Sohrt A; Augustin M; Hammond E; Reich K
J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2566-2573. PubMed ID: 32364296
[TBL] [Abstract][Full Text] [Related]
10. Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
Garber C; Plotnikova N; Au SC; Sorensen EP; Gottlieb A
J Drugs Dermatol; 2015 Aug; 14(8):846-52. PubMed ID: 26267729
[TBL] [Abstract][Full Text] [Related]
11. Patterns of biologic therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
Iskandar IYK; Ashcroft DM; Warren RB; Evans I; McElhone K; Owen CM; Burden AD; Smith CH; Reynolds NJ; Griffiths CEM
Br J Dermatol; 2017 May; 176(5):1297-1307. PubMed ID: 27589476
[TBL] [Abstract][Full Text] [Related]
12. Treatment patterns and annual biologic costs in US veterans with rheumatic conditions or psoriasis.
Sauer BC; Teng CC; He T; Leng J; Lu CC; Walsh JA; Shah N; Harrison DJ; Tang DH; Cannon GW
J Med Econ; 2016; 19(1):34-43. PubMed ID: 26337538
[TBL] [Abstract][Full Text] [Related]
13. Adverse Medical Conditions Across Treatment Options in Patients With Psoriasis: A Claims-Based Analysis.
Wu JJ; Armstrong A; Singh R; Cloutier M; Gauthier-Loiselle M; Gagnon-Sanschagrin P; Arikan D; Fleischer A; Guérin A; Ganguli A
J Drugs Dermatol; 2018 Nov; 17(11):1211-1218. PubMed ID: 30500143
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis.
Bissonnette R; Kerdel F; Naldi L; Papp K; Galindo C; Langholff W; Tang KL; Szapary P; Fakharzadeh S; Srivastava B; Goyal K; Gottlieb AB
J Drugs Dermatol; 2017 Oct; 16(10):1002-1013. PubMed ID: 29036254
[TBL] [Abstract][Full Text] [Related]
15. Treatment patterns and therapy effectiveness in psoriasis patients initiating biologic therapy in England.
Khalid JM; Fox KM; Globe G; Maguire A; Chau D
J Dermatolog Treat; 2014 Feb; 25(1):67-72. PubMed ID: 23336246
[TBL] [Abstract][Full Text] [Related]
16. Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis.
Feldman SR; Koo JY; Johnson LA; Preston NJ
Cutis; 2009 Oct; 84(4 Suppl):25-32. PubMed ID: 19916299
[TBL] [Abstract][Full Text] [Related]
17. Biologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population.
Doshi JA; Takeshita J; Pinto L; Li P; Yu X; Rao P; Viswanathan HN; Gelfand JM
J Am Acad Dermatol; 2016 Jun; 74(6):1057-1065.e4. PubMed ID: 26946986
[TBL] [Abstract][Full Text] [Related]
18. The evolving role of topical treatments in adjunctive therapy for moderate to severe plaque psoriasis.
Lebwohl M; Colón LE
Cutis; 2007 Nov; 80(5 Suppl):29-40. PubMed ID: 18154221
[TBL] [Abstract][Full Text] [Related]
19. Treatment patterns in moderate-to-severe plaque psoriasis: results from a Belgian cross-sectional study (DISCOVER).
Lambert J; Ghislain PD; Lambert J; Cauwe B; Van den Enden M
J Dermatolog Treat; 2017 Aug; 28(5):394-400. PubMed ID: 27791446
[TBL] [Abstract][Full Text] [Related]
20. Biologic therapy with or without topical treatment in psoriasis: what does the current evidence say?
Jensen JD; Delcambre MR; Nguyen G; Sami N
Am J Clin Dermatol; 2014 Oct; 15(5):379-85. PubMed ID: 25027461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
